Page last updated: 2024-10-26

dilazep and Basilar Artery Insufficiency

dilazep has been researched along with Basilar Artery Insufficiency in 1 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Research Excerpts

ExcerptRelevanceReference
"Patients with vertebrobasilar insufficiency tend to develop transient, repeated vertigo."1.30Vertigo secondary to hypotension: the relationship between therapeutic effects and hearing. ( Ito, F; Kamada, H; Tanaka, K, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, F1
Tanaka, K1
Kamada, H1

Other Studies

1 other study available for dilazep and Basilar Artery Insufficiency

ArticleYear
Vertigo secondary to hypotension: the relationship between therapeutic effects and hearing.
    Auris, nasus, larynx, 1998, Volume: 25, Issue:2

    Topics: Adenosine Triphosphate; Adult; Aged; Audiometry, Pure-Tone; Diagnosis, Differential; Dilazep; Drug T

1998